Adaptive Biotechnologies(DE:1HM)
€26.66+2.11 (+13.79%)
DE:1HM
Adaptive Biotechnologies Revenue
€26.66
At close:+2.11 (+13.79%)
Adaptive Biotechnologies (1HM) Revenue
3 Followers
Adaptive Biotechnologies Revenue
Adaptive Biotechnologies had a revenue of 83.90M in the quarter ending Sep 30, 2026, with 17.26%. This bring the company's revenue in the last twelve months to 298.01M, Decreased 3.27%. In the fiscal year ending Dec 31, 2025, Adaptive Biotechnologies had annual revenue of 276.98M with 54.77% growth.
- Revenue (ttm)
- 298.01M
- Revenue Growth
- 13.21%
- P/S Ratio
- 15.46
- Revenue/Employee
- EUR 443,872
- Employees
- 624
- Market Cap
- EUR 4.28B
Revenue Chart
Adaptive Biotechnologies Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 276.98M | 98.02M | 54.77% |
| Dec 31, 2024 | 178.96M | 8.68M | 5.10% |
| Dec 31, 2023 | 170.28M | -15.03M | -8.11% |
| Dec 31, 2022 | 185.31M | 30.96M | 20.06% |
| Dec 31, 2021 | 154.34M | 55.96M | 56.88% |
| Dec 31, 2020 | 98.38M | 13.31M | 15.65% |
| Dec 31, 2019 | 85.07M | 29.41M | 52.83% |
| Dec 31, 2018 | 55.66M | 17.21M | 44.77% |
| Dec 31, 2017 | 38.45M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.